Ref ID: 19492
Author:
I Valsecchi1*, R Beau1, JP Latgé1
Author address:
1Aspergillus Unit, Pasteur Institute, Paris, France
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
The emergence of A. fumigatus triazole resistant strains makes the antifungal triazole treatment
obsolete for patients colonized by resistant strains. There are three known triazole resistance
mechanisms in A. fumigatus: Cyp51A aminoacid substitutions due to point mutations; Cyp51A
overexpression due to a tandem repeats in their promoter, and overexpression of efflux pumps that
expel azoles consuming energy or exchanging H+. In order to understand the low environmental
dispersion of some of the A. fumigatus triazole resistant strains, we decided to analyze the fitness
in vivo and in vitro of A. fumigatus strains carrying the mutations M220K or G54W.
Methods:
M220K or G54W Cyp51A mutants were constructed with a barcode of 40 specific nucleotides long,
which allowed us to design primers in order to difference and quantify them by qPCR. To restore the
wild type (wt) phenotype, complemented M220K and G54W Cyp51A strains were also constructed.
Sequencing and testing for itraconazole sensitivity were carried out for all strains.
Results:
M220K or G54W Cyp51A mutants became itraconazole resistant with a MIC ≥ 30 μg/ml after
transformation. No significant differences in ct values between wt and mutant strains were found, in
vitro or in lungs of immune-suppressed mice. The complemented strains restored the phenotype as
wt, MICs (8804; 0.25 μg/ml),
Conclusion:
Wt and mutants strains grew comparably in vitro and in vivo assays. Reversion to wt suggested that
the triazole resistance was due to only the presence of these point mutations.
Abstract Number: 20
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a